Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

ApoLive-Glo™ Multiplex Assay Technical Manual

Instructions for Use of Product(s)
G6410, G6411

Literature # TM325

The ApoLive-Glo™ Multiplex Assay combines two assay chemistries to assess viability and caspase activation events within a single assay well. The first part of the assay measures the activity of a protease marker of cell viability. The live-cell protease activity is restricted to intact viable cells and is measured using a fluorogenic, cell-permeant, peptide substrate (glycyl-phenylalanyl-amino fluorocoumarin; GF-AFC). The substrate enters intact cells, where it is cleaved by the live-cell protease activity to generate a fluorescent signal proportional to the number of living cells (Figure 1). This live-cell protease becomes inactive upon loss of cell membrane integrity and leakage into the surrounding culture medium. The second part of the assay uses the Caspase-Glo™ Assay technology to detect caspase-3/7 activation, which is a key biomarker of apoptosis. The assay allows you to measure viability and apoptosis in the same sample well.

Summary of Changes, 3/15 Revision
The following change was made to the 3/15 version of this document:
Patent information and related products sections were updated.

Printed in USA. Revised 3/15.

Experienced User Protocols